[Patients with panic disorder: a 5-year follow-up study]

Area of Science:

• Psychiatry
• Clinical Psychology
• Pharmacology

Background:

• Panic disorder is a significant psychiatric condition requiring effective long-term management.
• Previous short-term trials have established the efficacy of certain medications, but long-term outcomes require further investigation.
• Understanding the sustained impact of initial treatments is crucial for guiding clinical practice.

Purpose of the Study:

• To assess the long-term clinical course and evolution of panic disorder in patients treated in a previous 8-week trial.
• To evaluate the effectiveness of initial treatments (Alprazolam, Imipramine, placebo) over a 5-year period.
• To examine subsequent treatment choices and identify differences among patients based on their original medication group.

Main Methods:

• A 5-year follow-up of 48 outpatients diagnosed with panic disorder.
• Analysis of clinical evolution, remission rates, and symptom persistence.
• Assessment of initial treatment efficacy and subsequent treatment patterns.

Main Results:

• Long-term outcomes and clinical evolution of panic disorder were evaluated.
• Effectiveness of Alprazolam, Imipramine, and placebo from the original trial was assessed over 5 years.
• Differences in outcomes were analyzed based on the initial treatment received.

Conclusions:

• The study provides insights into the long-term trajectory of panic disorder following short-term treatment.
• Findings contribute to understanding the sustained effects of Alprazolam and Imipramine compared to placebo.
• This research informs clinical decision-making regarding the long-term management of panic disorder.